QL1706 for the Neoadjuvant Treatment of HR+/HER2- Breast Cancer
Clinical trial NCT06967103 · RECRUITING
Trial details
- NCT number
- NCT06967103
- Sponsor
- Henan Cancer Hospital
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-08
- Primary completion
- 2027-05-31
- Enrollment
- 238
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.